Tax Considerations
The University of Michigan’s policy on the distribution of tech transfer licensing revenues provides that a percentage of net revenues are shared with U-M employees that are inventors or developers (“inventors”) of the licensed patent rights, materials, software, or other licensed inventions. Occasionally, a U-M inventor will desire to redirect (or “waive”) all or a portion of his or her share of revenues to a U-M entity.
Technology Transfer Policy
This Policy implements Section 3.10 of the Bylaws of the Board of Regents. The Policy further defines the ownership, distribution, and commercialization of rights associated with Intellectual Property developed at or received by the University of Michigan, and describes the general obligations associated with the technology licensing process.
The Advance Grant
The ADVANCE Grant program like MTRAC, will provide a strong incentive for faculty with early stage technologies at the Michigan public universities to engage with their university’s Technology Transfer Office (TTO) and commercialization activities.
Toyota Research Institute
Building on a successful five-year collaboration with University of Michigan faculty, the Toyota Research Institute will renew its research partnership with U-M for an additional five years, with projects funded up to $3M per year, TRI announced Jan. 26.
U-M Therapeutic Innovation Fund
The U-M Therapeutic Innovation Fund, offered by the Michigan Center for Therapeutic Innovation (MCTI) and Fast Forward Medical Innovation (FFMI), is a five-year, $2.5 million fund created in 2016 to accelerate the discovery and translation of therapeutic candidates at the University of Michigan.
U.S. Bayh-Dole Act
The U.S. Bayh-Dole Act of 1980 allows universities and other non-profit institutions to have ownership rights to discoveries resulting from federally-funded research, provided certain obligations are met.
Wolverine Venture Fund
Wolverine Venture Fund is an evergreen fund that seeks investment opportunities in SaaS, Biotech, Health Tech, Advanced Materials, and other advanced and emerging technologies. The fund invests in priced series seed, A, or B rounds alongside established venture capital firms serving as lead investors.
